STOCK TITAN

Verano Announces Upcoming Conference Participation

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Verano Holdings Corp. announces participation in upcoming conferences
Positive
  • None.
Negative
  • None.

CHICAGO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that members of its executive leadership team will participate in the following conferences:

ATB Life Sciences Institutional Investor Conference
Darren Weiss, President, and Aaron Miles, Chief Investment Officer, will participate in a fireside chat and 1x1 investor meetings.
DATE: September 20, 2023
LOCATION: New York City
TIME: 1:45 p.m. ET 

Benzinga Cannabis Capital Conference
Darren Weiss, President, will participate in a panel.
DATE: September 27, 2023
LOCATION: Chicago
TIME: 10:40 a.m. CT

Aaron Miles, Chief Investment Officer, will participate in a panel.
DATE: September 27, 2023
LOCATION: Chicago
TIME: 2:40 p.m. CT

AGP Cannabis Conference
Darren Weiss, President, will participate in a panel and 1x1 investor meetings.
DATE: October 4, 2023
LOCATION: Virtual
TIME: 12:00 p.m. ET

Jefferies Cannabis Summit
Management will participate in a panel and 1x1 investor meetings.
DATE: October 25, 2023
LOCATION: New York City

About Verano

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano offers a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf and MÜV dispensary banners and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Verano, MÜV, Savvy, BITS, Encore, and Avexia. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1,000,000 square feet of cultivation capacity. Learn more at www.verano.com.

Contacts:
Media
Verano
Steve Mazeika
Vice President, Communications
Steve.Mazeika@verano.com
312-348-4430

Investors
Verano
Julianna Paterra, CFA
Vice President, Investor Relations
investors@verano.com

Forward Looking Statements

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q for 2023 filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

###


VERANO HLDGS CORP

OTC:VRNOF

VRNOF Rankings

VRNOF Latest News

VRNOF Stock Data

1.37B
261.73M
15.62%
10.66%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Chicago